Mass Medical Angels

Mass Medical Angels (MMA) is a prominent angel investment group based in Boston, United States, dedicated to fostering innovation within the healthcare and life sciences sectors. Established to bridge the funding gap for early-stage medical ventures, MMA provides not only crucial capital but also invaluable mentorship and strategic guidance to its portfolio companies. Their focus spans a broad spectrum of healthcare innovations, including medical devices, diagnostics, therapeutics, and health IT solutions, all aimed at addressing significant unmet medical needs.

MMA's investment philosophy emphasizes identifying companies with strong intellectual property, scalable business models, and experienced management teams. They actively seek out ventures that demonstrate a clear path to market and possess the potential for significant impact on patient care and healthcare efficiency. The group leverages the collective expertise of its diverse membership, which comprises seasoned entrepreneurs, clinicians, scientists, and business leaders, providing portfolio companies with a rich network of industry connections and operational insights.

Since its inception, Mass Medical Angels has made a substantial impact on the regional life sciences ecosystem, having invested over $20 million into more than 70 companies. Their typical investment per round ranges from $250,000 to $1,000,000, often participating in syndicated rounds with other angel groups or venture capital firms. This strategic approach allows them to support promising startups through critical development milestones, from proof-of-concept to commercialization.

Beyond capital, MMA's commitment to its portfolio extends to active engagement, helping companies navigate regulatory pathways, refine business strategies, and build strong teams. This hands-on approach is a cornerstone of their value proposition, distinguishing them as more than just a source of funding. Their role is vital in nurturing the next generation of healthcare innovators in the highly competitive and capital-intensive medical technology landscape.